Skip to main content
# Title Research Year
191 A Randomized, Double Blind, Placebo-Controlled clinical trial of efficacy of treatment with zinc in children with intractable epilepsy 2015
192 Impact Factor: 1.83

The Number of GT(n) Repeats in the Haemoxygenase-1 Gene Promoter is Increased in Pediatric Heart Failure but is Unrelated to Renal, Antioxidant and Anti-inflammatory Markers
2015
193 Immunogenicty of recombinant hepatitis B vaccine among routinely vaccinated healthy and chronically ill children in Assiut Upper Egypt 2015
194 Prothrombotic risk factors and antithrombotic therapy in children with ischemic stroke 2015
195 Evaluation of pulmonary function changes
in children with type 1 diabetes mellitus in
Upper Egypt
2015
196 A Randomized, Double Blind, Placebo-Controlled clinical trial of efficacy of treatment with zinc in children with intractable epilepsy 2015
197 Impact Factor: 1.83

The Number of GT(n) Repeats in the Haemoxygenase-1 Gene Promoter is Increased in Pediatric Heart Failure but is Unrelated to Renal, Antioxidant and Anti-inflammatory Markers
2015
198 Fetuin-A and high sensitivity-CRP in children with chronic kidney diseases. 2015
199 Immunogenicty of recombinant hepatitis B vaccine among routinely vaccinated healthy and chronically ill children in Assiut Upper Egypt 2015
200 Risk genes and autoantibodies in Egyptian children with type 1 diabetes–low frequency of autoantibodies in carriers of the HLA‐DRB1* 04: 05‐DQA1* 03‐DQB1* 02 risk haplotype 2015